Mouse Anti-Human CD55-FITC

Cat# 9661-02S

Size : 25tests

Brand : Southern Biotech

Contact local distributor :


Phone : +1 850 650 7790

More Information
Clone 143-30
Isotype Mouse IgG1κ
Isotype Control Mouse IgG1-FITC (15H6)
Specificity Human CD55
Alternative Names DAF, decay accelerating factor
Description CD55, also known as decay accelerating factor (DAF), is an 80 kDa GPI-anchored single chain glycoprotein that is expressed on all cells in contact with serum including all hematopoietic cells and the vascular endothelium. A soluble form of CD55 is present in plasma and body fluids. CD55 is a member of the regulator of complement activity (RCA) family of proteins and is thought to play a role in the protection of cells from damage by autologous complement by preventing the amplification steps of the complement cascade. CD55 expression increases upon T cell activation and antibodies to CD55 are mitogenic in the presence of phorbol esters.
Immunogen PHA activated peripheral blood mononuclear cells
Conjugate FITC (Fluorescein)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Monoclonal
Concentration Lot specific
Volume 0.25 mL or 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light
Applications Flow Cytometry – Quality tested 5,6
Immunohistochemistry-Frozen Sections – Reported in literature 1
Immunohistochemistry-Paraffin Sections – Reported in literature 2
Immunoprecipitation – Reported in literature 3
Western Blot-Non-Reducing – Reported in literature 4

RRID Number AB_2797048
Gene ID 1604 (Human)
Gene ID Symbol CD55 (Human)
Gene ID Aliases CR; TC; DAF; CROM; CHAPLE
UniProt ID P08174 (Human
UniProt Name DAF_HUMAN (Human)
Documentation
Technical Bulletin Safety Datasheet

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

  1. 1. Koretz K, Brüderlein S, Henne C, Möller P. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br J Cancer. 1992;66:810-4. (IHC-FS)
  2. 2. Wu J, Lei L, Wang S, Gu D, Zhang J. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma. J Biomed Biotechnol. 2012;2012:587672. (IHC-PS)
  3. 3. Stefanová I, Hořejší V, Ansotegui IJ, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science. 1991;254:1016-9. (IP)
  4. 4. Clayton A, Harris CL, Court J, Mason MD, Morgan BP. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur J Immunol. 2003;33:522-31. (WB)
  5. 5. Zeuke S, Ulmer A, Kusumoto S, Katus HA, Heine H. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res. 2002;56:126-34. (FC)
  6. 6. Haas P, Aggermann T, Nagl M, Steindl-Kuscher K, Krugluger W, Binder S. Implication of CD21, CD35, and CD55 in the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2011;152:396-9. (FC)